Role of Fibroblasts in the Subtype Specific Therapeutic Effects of Nintedanib in Non-Small Cell Lung Cancer (NSCLC)

被引：0
|
作者：
Gabasa, Marta [1 ]
Ikemori, Rafael [1 ]
Solca, Flavio [2 ]
Hilberg, Frank [2 ]
Reguart, Noemi [3 ]
Alcaraz, Jordi [1 ]
机构：
[1] Univ Barcelona, Dept Biomed, Fac Med, Barcelona, Spain
[2] Boehringer Ingelheim Rcv GmbH & Co Kg, Vienna, Austria
[3] Hosp Clin Barcelona, Barcelona, Spain
来源：
JOURNAL OF THORACIC ONCOLOGY | 2017年 / 12卷 / 01期
关键词：
nintedanib; TGF-beta; tumor microenvironment; cancer associated fibroblasts;
D O I：
10.1016/j.jtho.2016.11.292
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
OA11.06
引用
收藏
页码：S287 / S288
页数：2
相关论文
共 50 条
  • [1] Prognostic and therapeutic aspects of non-small cell lung cancer (NSCLC)
    Biasco, G
    Tamberi, S
    2ND INTERNATIONAL CONGRESS OF THORAX SURGERY, 1998, : 7 - 8
  • [2] ACCURACY OF CYTOLOGY IN THE IDENTIFICATION OF HISTOLOGIC SUBTYPE IN NON-SMALL CELL LUNG CANCER (NSCLC)
    Nizzoli, R.
    Guazzi, A.
    Bartolotti, M.
    Gelsomino, F.
    Tiseo, M.
    Majori, M.
    Ferrari, L.
    De Filippo, M.
    Rindi, G.
    Ardizzoni, A.
    ACTA CYTOLOGICA, 2010, 54 (03) : 406 - 407
  • [3] ACCURACY OF CYTOLOGY IN THE IDENTIFICATION OF HISTOLOGIC SUBTYPE IN NON-SMALL CELL LUNG CANCER (NSCLC)
    Nizzoli, R.
    Bartolotti, M.
    Gelsomino, F.
    Tiseo, M.
    Majori, M.
    Ferrari, L.
    De Filippo, M.
    Guazzi, A.
    Rindi, G.
    Ardizzoni, A.
    ANNALS OF ONCOLOGY, 2009, 20
  • [4] ACCURACY OF CYTOLOGY IN THE IDENTIFICATION OF HISTOLOGIC SUBTYPE IN NON-SMALL CELL LUNG CANCER (NSCLC)
    Tiseo, M.
    Nizzoli, R.
    Guazzi, A.
    Bartolotti, M.
    Gelsomino, F.
    Majori, M.
    Ferrari, L.
    De Filippo, M.
    Silini, E. M.
    Ardizzoni, A.
    JOURNAL OF THORACIC ONCOLOGY, 2010, 5 (05) : S47 - S47
  • [5] The role of ifosfamide in non-small cell lung cancer (NSCLC) treatment
    Manegold, K
    EXPERIMENTAL ONCOLOGY, 1996, 18 (01): : 69 - 72
  • [6] Role of chemokines in resectable non-small cell lung cancer (NSCLC)
    Drosslerova, M.
    Sterclova, M.
    Vasakova, M.
    Taskova, A.
    Hytych, V.
    Horazd'ovsky, P.
    Richterova, E.
    Smetakova, M.
    Havel, L.
    ANNALS OF ONCOLOGY, 2019, 30
  • [7] Angiogenesis inhibition as a therapeutic strategy in non-small cell lung cancer (NSCLC)
    Hall, Richard D.
    Le, Tri M.
    Haggstrom, Daniel E.
    Gentzler, Ryan D.
    TRANSLATIONAL LUNG CANCER RESEARCH, 2015, 4 (05) : 515 - 523
  • [8] Prevalence of KRAS Subtype Alterations in Non-Small Cell Lung Cancer (NSCLC) with Brain Metastases
    Karim, N. Abdel
    Polani, F.
    Se, B.
    Macera, L.
    JOURNAL OF THORACIC ONCOLOGY, 2023, 18 (11) : S246 - S246
  • [9] β-catenin in non-small cell lung cancer (NSCLC)
    Swinson, DEB
    Lolljee, J
    Edwards, JG
    Jones, JL
    Cox, G
    Richardson, D
    O'Byrne, KJ
    BRITISH JOURNAL OF CANCER, 2002, 86 : S59 - S60
  • [10] Micrometastases in non-small cell lung cancer (NSCLC)
    Passlick, B
    LUNG CANCER, 2001, 34 : S25 - S29
12345